Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA)
Collyer BS., Irvine MA., Hollingsworth TD., Bradley M., Anderson RM.